On Monday, May 14, 2018, Pennsylvania became the first state to add opioid addiction to its list of approved conditions for medicinal cannabis.
The online news service NJ Spotlight hosted a half-day event on May 11, 2018, at the Hilton Garden Inn in Hamilton, New Jersey, titled “Marijuana Legalization in NJ: Understanding the Opportunity and Challenges.” The event was sponsored by WeedMaps, Archer Attorneys at
Mike James, a free agent with the National Football League (NFL) and former running back for the Tampa Bay Buccaneers and the Detroit Lions, is the first NFL athlete to apply for a therapeutic use exemption (TUE) for cannabis. James’s physician, Dr.
Steep Hill, the global leader in cannabis science, genetics, research, testing, and analytics headquartered in Berkeley, California, announced plans this week to expand into the global cannabis market.
The second annual World Medical Cannabis Conference & Expo was held April 12–14, 2018 in Pittsburgh, Pennsylvania.
Join your colleagues in conversation, respond to hot topic questions, and stay up-to-date on the latest Cannabis Science and Technology articles and news.
Two studies came out earlier this week in JAMA Internal Medicine stating that there is a potential link between cannabis legalization and a decrease in the amount of prescriptions for opioids (1,2).
The annual Pittcon Conference and Expo was held February 26–March 1, 2018, in Orlando, Florida, and featured a few tracks and special events dedicated to cannabis science.
The 4th annual Emerald Conference hosted by Emerald Scientific was held February 15–16, 2018, in San Diego, California. The conference featured two days of technical talks from various leaders in the cannabis industry, an exhibit hall, and a poster session.